The European Patent Office (EPO)’s requirement for the description of a patent to confirm the claims at the final stage of grant or opposition proceedings is coming under attack, as Jakob Pade ...
Court Will Revisit Ariad Case to Clarify the Amount of Disclosure Necessary in Patents The Federal Circuit recently agreed to rehear Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co. en banc to resolve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results